Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 150 No. 0708 (2020)

Plaque vulnerability in patients with high- and moderate-grade carotid stenosis – comparison of plaque features on MRI with histopathological findings

  • Pascal Tapis
  • Marwan El-Koussy
  • Ekkehard Hewer
  • Marie-Luise Mono
  • Michael Reinert
DOI
https://doi.org/10.4414/smw.2020.20174
Cite this as:
Swiss Med Wkly. 2020;150:w20174
Published
17.02.2020

Summary

BACKGROUND

Plaque vulnerability plays an important role in determining the risk of subsequent cerebrovascular events in patients with carotid stenosis. Plaque morphology magnetic resonance imaging (MRI) can be used to assess plaque vulnerability. We therefore set out to examine the diagnostic accuracy of plaque morphology MRI compared with histopathological findings as gold standard in moderate- to high-grade carotid stenosis at our centre.

METHODS

A total of 36 patients with moderate- to high-grade carotid stenosis underwent plaque morphology MRI with a multisequence protocol (time of flight sequence, dark blood T1- [native and post-gadolinium] and T2-weighted sequence with fat suppression). The status of the fibrous cap, calcification, lipid-rich necrotic core (LRNC) and intraplaque haemorrhage (IPH) were assessed by means of qualitative MR analysis of plaque characteristics and compared with the histopathological findings. Detection statistics (sensitivity, specificity), chi-squared test, Cohen’s kappa (κ), percentage of agreement and phi coefficient (φ) were determined.

RESULTS

Carotid stenosis was symptomatic (transient ischaemic attack, amaurosis fugax or ischaemic stroke in the territory of the stenosed carotid artery) in 25 patients (69.5%). Twenty-eight patients (77.8%) had a high-grade and eight patients (12.2%) a moderate-grade stenosis. Significant congruence between MRI and histology was found for plaque calcification (89% histology, 75% MRI, κ = 0.364, p = 0.013), for LRNC (89% histology, 53% MRI, κ = 0.245, p = 0.025) and IPH (75% histology, 53% MRI, κ = 0.314, p = 0.035). In a subgroup of patients with symptomatic stenosis, the agreement for LRNC and IPH was slightly better (LRNC κ = 0.390, p = 0.014; IPH κ = 0.386, p = 0.045). Status of the fibrous cap, essentially ulceration, did not show any significant agreement (κ = 0.032, p = 0.842). There was significant correlation between LRNC on MRI and symptomatic carotid stenosis (φ = 0.339, p = 0.042).

CONCLUSION

Plaque morphology MRI is capable of identifying the main components of atherosclerotic plaques with moderate to good accuracy as compared with histopathological findings as gold standard. LRNC seems to be a useful marker of plaque vulnerability and warrants its use in clinical decision making.

References

  1. Orrapin S, Rerkasem K. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. 2017;6:CD001081.
  2. Huibers A, de Borst GJ, Wan S, Kennedy F, Giannopoulos A, Moll FL, et al. Non-invasive Carotid Artery Imaging to Identify the Vulnerable Plaque: Current Status and Future Goals. Eur J Vasc Endovasc Surg. 2015;50(5):563–72. doi:.https://doi.org/10.1016/j.ejvs.2015.06.113
  3. North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke. 1991;22(6):711–20. doi:.https://doi.org/10.1161/01.STR.22.6.711
  4. Qureshi AI, Alexandrov AV, Tegeler CH, Hobson RW, 2nd, Dennis Baker J, Hopkins LN ; American Society of Neuroimaging; Society of Vascular and Interventional Neurology. Guidelines for screening of extracranial carotid artery disease: a statement for healthcare professionals from the multidisciplinary practice guidelines committee of the American Society of Neuroimaging; cosponsored by the Society of Vascular and Interventional Neurology. J Neuroimaging. 2007;17(1):19–47. doi:.https://doi.org/10.1111/j.1552-6569.2006.00085.x
  5. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;339(20):1415–25. doi:.https://doi.org/10.1056/NEJM199811123392002
  6. Rothwell PM, Warlow CP ; European Carotid Surgery Trialists’ Collaborative Group. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. Lancet. 1999;353(9170):2105–10. doi:.https://doi.org/10.1016/S0140-6736(98)11415-0
  7. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273(18):1421–8.https://doi.org/10.1001/jama.1995.03520420037035
  8. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al., MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363(9420):1491–502. doi:.https://doi.org/10.1016/S0140-6736(04)16146-1
  9. Cicha I, Wörner A, Urschel K, Beronov K, Goppelt-Struebe M, Verhoeven E, et al. Carotid plaque vulnerability: a positive feedback between hemodynamic and biochemical mechanisms. Stroke. 2011;42(12):3502–10. doi:.https://doi.org/10.1161/STROKEAHA.111.627265
  10. Brinjikji W, Huston J, 3rd, Rabinstein AA, Kim GM, Lerman A, Lanzino G. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability. J Neurosurg. 2016;124(1):27–42. doi:.https://doi.org/10.3171/2015.1.JNS142452
  11. Truijman MT, Kooi ME, van Dijk AC, de Rotte AA, van der Kolk AG, Liem MI, et al. Plaque At RISK (PARISK): prospective multicenter study to improve diagnosis of high-risk carotid plaques. Int J Stroke. 2014;9(6):747–54. doi:.https://doi.org/10.1111/ijs.12167
  12. Redgrave JN, Lovett JK, Rothwell PM. Histological features of symptomatic carotid plaques in relation to age and smoking: the oxford plaque study. Stroke. 2010;41(10):2288–94. doi:.https://doi.org/10.1161/STROKEAHA.110.587006
  13. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA. 2004;292(15):1845–52. doi:.https://doi.org/10.1001/jama.292.15.1845
  14. Wahlgren CM, Zheng W, Shaalan W, Tang J, Bassiouny HS. Human carotid plaque calcification and vulnerability. Relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology. Cerebrovasc Dis. 2009;27(2):193–200. doi:.https://doi.org/10.1159/000189204
  15. Gao T, Zhang Z, Yu W, Zhang Z, Wang Y. Atherosclerotic carotid vulnerable plaque and subsequent stroke: a high-resolution MRI study. Cerebrovasc Dis. 2009;27(4):345–52. doi:.https://doi.org/10.1159/000202011
  16. Mono ML, Karameshev A, Slotboom J, Remonda L, Galimanis A, Jung S, et al. Plaque characteristics of asymptomatic carotid stenosis and risk of stroke. Cerebrovasc Dis. 2012;34(5-6):343–50. doi:.https://doi.org/10.1159/000343227
  17. Barth A, Lukes A, Remonda L, Mattle H, Seiler RW. [Results and role of carotid endarterectomy]. Schweiz Med Wochenschr. 2000;130(29-30):1062–71. doi:.https://doi.org/10.1016/S0140-6736(04)16146-1
  18. Reinert M, Mono ML, Kuhlen D, Mariani L, Barth A, Beck J, et al. Restenosis after microsurgical non-patch carotid endarterectomy in 586 patients. Acta Neurochir (Wien). 2012;154(3):423–31, discussion 431. doi:.https://doi.org/10.1007/s00701-011-1233-9
  19. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108(14):1664–72. doi:.https://doi.org/10.1161/01.CIR.0000087480.94275.97
  20. Naim C, Douziech M, Therasse E, Robillard P, Giroux MF, Arsenault F, et al. Vulnerable atherosclerotic carotid plaque evaluation by ultrasound, computed tomography angiography, and magnetic resonance imaging: an overview. Can Assoc Radiol J. 2014;65(3):275–86. doi:.https://doi.org/10.1016/j.carj.2013.05.003
  21. Parmar JP, Rogers WJ, Mugler JP, 3rd, Baskurt E, Altes TA, Nandalur KR, et al. Magnetic resonance imaging of carotid atherosclerotic plaque in clinically suspected acute transient ischemic attack and acute ischemic stroke. Circulation. 2010;122(20):2031–8. doi:.https://doi.org/10.1161/CIRCULATIONAHA.109.866053
  22. Yuan C, Zhang SX, Polissar NL, Echelard D, Ortiz G, Davis JW, et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation. 2002;105(2):181–5. doi:.https://doi.org/10.1161/hc0202.102121
  23. Mitsumori LM, Hatsukami TS, Ferguson MS, Kerwin WS, Cai J, Yuan C. In vivo accuracy of multisequence MR imaging for identifying unstable fibrous caps in advanced human carotid plaques. J Magn Reson Imaging. 2003;17(4):410–20. doi:.https://doi.org/10.1002/jmri.10264
  24. Murphy RE, Moody AR, Morgan PS, Martel AL, Delay GS, Allder S, et al. Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation. 2003;107(24):3053–8. doi:.https://doi.org/10.1161/01.CIR.0000074204.92443.37
  25. Singh N, Moody AR, Gladstone DJ, Leung G, Ravikumar R, Zhan J, et al. Moderate carotid artery stenosis: MR imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology. 2009;252(2):502–8. doi:.https://doi.org/10.1148/radiol.2522080792
  26. Salem MK, Sayers RD, Bown MJ, West K, Moore D, Nicolaides A, et al. Patients with recurrent ischaemic events from carotid artery disease have a large lipid core and low GSM. Eur J Vasc Endovasc Surg. 2012;43(2):147–53. doi:.https://doi.org/10.1016/j.ejvs.2011.11.008
  27. Xia Z, Yang H, Yuan X, Wang J, Zhang S, Zhang L, et al. High-resolution magnetic resonance imaging of carotid atherosclerotic plaques - a correlation study with histopathology. Vasa. 2017;46(4):283–90. doi:.https://doi.org/10.1024/0301-1526/a000626
  28. Hellings WE, Peeters W, Moll FL, Piers SR, van Setten J, Van der Spek PJ, et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation. 2010;121(17):1941–50. doi:.https://doi.org/10.1161/CIRCULATIONAHA.109.887497
  29. Kurosaki Y, Yoshida K, Endo H, Chin M, Yamagata S. Association between carotid atherosclerosis plaque with high signal intensity on T1-weighted imaging and subsequent ipsilateral ischemic events. Neurosurgery. 2011;68(1):62–7, discussion 67. doi:.https://doi.org/10.1227/NEU.0b013e3181fc60a8
  30. Yuan C, Mitsumori LM, Ferguson MS, Polissar NL, Echelard D, Ortiz G, et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation. 2001;104(17):2051–6. doi:.https://doi.org/10.1161/hc4201.097839
  31. Saam T, Ferguson MS, Yarnykh VL, Takaya N, Xu D, Polissar NL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol. 2005;25(1):234–9. doi:.https://doi.org/10.1161/01.ATV.0000149867.61851.31

Most read articles by the same author(s)